Mechanism of Action of Ipratropium Bromide
Introduction Ipratropium bromide is a short-acting anticholinergic (antimuscarinic) bronchodilator primarily used in the management of chronic obstructive pulmonary disease (COPD) and, in some cases, asthma. It is a quaternary ammonium compound derived from atropine, designed for inhalational use with minimal systemic absorption. Its main action is to reduce bronchoconstriction mediated by the parasympathetic nervous system. … Read more
